Blood hypercoagulability and systemic inflammation in horses with heaves.

The research article discusses a study that compares the efficiency of blood coagulation in horses with heaves (a respiratory condition) to horses without heaves. The study discovered that horses with heaves exhibited signs of hypercoagulability and systemic inflammation, factors that may enhance airway dysfunction.

Research Methodology

• The researchers conducted an observational case-control study in which they compared the blood coagulation efficiency between horses affected by heaves and a control group.
• The study employed thrombelastography, a diagnostic method that evaluates the clotting efficiency of blood.
• Two experiments were carried out: one during an exacerbation period, where six horses with heaves and five without were examined. The second was during remission, with eight horses with heaves and eleven controls. In both, the horses were initially housed indoors and fed hay.
• The scientists took into account several factors, including functional fibrinogen levels, platelet count, hematology, and antithrombin.

Research Findings

• In the exacerbation phase, horses affected by heaves showed higher maximum amplitude and higher functional fibrinogen levels compared to the control group.
• Even in the remission period, horses with heaves showed higher maximum amplitude levels than normal horses.
• The results implied a hypercoagulable state and systemic inflammation in horses with heaves. This indicates that these horses produce blood clots more easily, and there’s widespread inflammation in their body.

Implications of the Research

• The findings suggest that the hypercoagulable state and systemic inflammation seen in horses with heaves could be a consequence of pulmonary inflammation.
• This could contribute to the maintenance of airway dysfunction, perpetuating the respiratory condition.
• The insights from this study could help in developing therapeutic interventions or management strategies for horses affected by heaves, aiming to prevent or limit the hypercoagulability and systemic inflammation.